Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer

ABSTRACT Background: Her-2 and ESR1 genes, that interact in the cell signaling pathway, are the most important molecular markers of breast cancer, which have been amplified or overexpressed in 30% and 70%, respectively. This study was performed to evaluate the gene expression levels of Her-2 and ESR1 genes in tumor cells and its adjacent normal tissue of breast cancer patients and compared them whit clinical-pathological features. Methods: In total, 80 tissue specimens from 40 patients, with an average age of 48.47 years, were examined by Real-time PCR technique, and ultimately evaluated the expression level of Her-2 and ESR1genes. The data were analyzed by REST 2009 V2.0.13 statistical software. Results: HER2 and ESR1 overexpression was identified in 19 (48%) and 12 (30%) of 40 patients respectively, which was higher and lower than that recorded in international statistics, respectively. ESR1 overexpression was associated with Stage 3A and lymph node involvement 2 (N2) (P = 0.04 and P = 0.047, respectively). No significant correlation was observed between the expression of HER2 and ESR1 and other clinical-pathological features, however, the relative differences were identified in the expression levels of genes between main group and groups that were classified according to the clinical-pathological features and age. Conclusions: Overexpression of Her-2 and ESR1 genes in the patients of our study are higher and lower than international statistics, respectively, indicating the differences in genetic, environmental and ethnic factors that involved in the developing of breast cancer.

Saved in:
Bibliographic Details
Main Authors: Nadergoli,Omid Kheyri, Feizi,Mohammad Ali Hosseinpour, Kafil,Hossein Samadi, Pouladi,Nasser, Hosseinzadeh,Ali, Rostamizadeh,Leila, Montazeri,Vahid, Fakhrjou,Ashraf, Sakhinia,Ebrahim, Seifi,Morteza
Format: Digital revista
Language:English
Published: Instituto de Tecnologia do Paraná - Tecpar 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132017000100317
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-89132017000100317
record_format ojs
spelling oai:scielo:S1516-891320170001003172017-10-03Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast CancerNadergoli,Omid KheyriFeizi,Mohammad Ali HosseinpourKafil,Hossein SamadiPouladi,NasserHosseinzadeh,AliRostamizadeh,LeilaMontazeri,VahidFakhrjou,AshrafSakhinia,EbrahimSeifi,Morteza Breast Cancer Her-2/neu ESR1 overexpression molecular marker real-time PCR ABSTRACT Background: Her-2 and ESR1 genes, that interact in the cell signaling pathway, are the most important molecular markers of breast cancer, which have been amplified or overexpressed in 30% and 70%, respectively. This study was performed to evaluate the gene expression levels of Her-2 and ESR1 genes in tumor cells and its adjacent normal tissue of breast cancer patients and compared them whit clinical-pathological features. Methods: In total, 80 tissue specimens from 40 patients, with an average age of 48.47 years, were examined by Real-time PCR technique, and ultimately evaluated the expression level of Her-2 and ESR1genes. The data were analyzed by REST 2009 V2.0.13 statistical software. Results: HER2 and ESR1 overexpression was identified in 19 (48%) and 12 (30%) of 40 patients respectively, which was higher and lower than that recorded in international statistics, respectively. ESR1 overexpression was associated with Stage 3A and lymph node involvement 2 (N2) (P = 0.04 and P = 0.047, respectively). No significant correlation was observed between the expression of HER2 and ESR1 and other clinical-pathological features, however, the relative differences were identified in the expression levels of genes between main group and groups that were classified according to the clinical-pathological features and age. Conclusions: Overexpression of Her-2 and ESR1 genes in the patients of our study are higher and lower than international statistics, respectively, indicating the differences in genetic, environmental and ethnic factors that involved in the developing of breast cancer.info:eu-repo/semantics/openAccessInstituto de Tecnologia do Paraná - TecparBrazilian Archives of Biology and Technology v.60 20172017-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132017000100317en10.1590/1678-4324-2017160733
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Nadergoli,Omid Kheyri
Feizi,Mohammad Ali Hosseinpour
Kafil,Hossein Samadi
Pouladi,Nasser
Hosseinzadeh,Ali
Rostamizadeh,Leila
Montazeri,Vahid
Fakhrjou,Ashraf
Sakhinia,Ebrahim
Seifi,Morteza
spellingShingle Nadergoli,Omid Kheyri
Feizi,Mohammad Ali Hosseinpour
Kafil,Hossein Samadi
Pouladi,Nasser
Hosseinzadeh,Ali
Rostamizadeh,Leila
Montazeri,Vahid
Fakhrjou,Ashraf
Sakhinia,Ebrahim
Seifi,Morteza
Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
author_facet Nadergoli,Omid Kheyri
Feizi,Mohammad Ali Hosseinpour
Kafil,Hossein Samadi
Pouladi,Nasser
Hosseinzadeh,Ali
Rostamizadeh,Leila
Montazeri,Vahid
Fakhrjou,Ashraf
Sakhinia,Ebrahim
Seifi,Morteza
author_sort Nadergoli,Omid Kheyri
title Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
title_short Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
title_full Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
title_fullStr Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
title_full_unstemmed Gene Expression Analyses of HER-2/neu and ESR1 in Patients with Breast Cancer
title_sort gene expression analyses of her-2/neu and esr1 in patients with breast cancer
description ABSTRACT Background: Her-2 and ESR1 genes, that interact in the cell signaling pathway, are the most important molecular markers of breast cancer, which have been amplified or overexpressed in 30% and 70%, respectively. This study was performed to evaluate the gene expression levels of Her-2 and ESR1 genes in tumor cells and its adjacent normal tissue of breast cancer patients and compared them whit clinical-pathological features. Methods: In total, 80 tissue specimens from 40 patients, with an average age of 48.47 years, were examined by Real-time PCR technique, and ultimately evaluated the expression level of Her-2 and ESR1genes. The data were analyzed by REST 2009 V2.0.13 statistical software. Results: HER2 and ESR1 overexpression was identified in 19 (48%) and 12 (30%) of 40 patients respectively, which was higher and lower than that recorded in international statistics, respectively. ESR1 overexpression was associated with Stage 3A and lymph node involvement 2 (N2) (P = 0.04 and P = 0.047, respectively). No significant correlation was observed between the expression of HER2 and ESR1 and other clinical-pathological features, however, the relative differences were identified in the expression levels of genes between main group and groups that were classified according to the clinical-pathological features and age. Conclusions: Overexpression of Her-2 and ESR1 genes in the patients of our study are higher and lower than international statistics, respectively, indicating the differences in genetic, environmental and ethnic factors that involved in the developing of breast cancer.
publisher Instituto de Tecnologia do Paraná - Tecpar
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132017000100317
work_keys_str_mv AT nadergoliomidkheyri geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT feizimohammadalihosseinpour geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT kafilhosseinsamadi geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT pouladinasser geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT hosseinzadehali geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT rostamizadehleila geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT montazerivahid geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT fakhrjouashraf geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT sakhiniaebrahim geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
AT seifimorteza geneexpressionanalysesofher2neuandesr1inpatientswithbreastcancer
_version_ 1756423971894460416